Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 1.6T | 1.6T | 1.5T |
Cost of revenue | — | 858.0B | 826.1B | 752.8B |
Gross profit | — | 714.4B | 751.7B | 751.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 575.5B | 535.5B | 492.3B |
Other operating expenses | — | 4.1B | — | — |
Operating income | — | 144.1B | 217.5B | 268.1B |
Non operating interest income | ||||
Income | — | 5.7B | 1.6B | 2.1B |
Expense | — | 4.7B | 24.3B | 19.1B |
Other income expense | — | — | — | — |
Pretax income | — | 115.5B | 189.5B | 252.4B |
Tax provision | — | 27.9B | 59.6B | 53.1B |
Net income | — | 87.6B | 129.9B | 199.2B |
Basic EPS | 3.4 | — | 2.2 | 3.3 |
Diluted EPS | 3.4 | — | 2.1 | 3.2 |
Basic average shares | 47.4B | — | 47.5B | 47.4B |
Diluted average shares | 48.1B | — | 48.8B | 47.8B |
EBITDA | — | 328.3B | 402.8B | 456.7B |
Net income from continuing op. | — | 87.6B | 129.9B | 199.2B |
Minority interests | — | -5.2B | -25.3B | -43.8B |
Preferred stock dividends | — | 0 | 0 | 0 |